Joakim Isendahl

Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial

Takashi Kadowaki, Joakim Isendahl, Usman Khalid et al. · The Lancet Diabetes & Endocrinology · 2022 · 279 citations

Obesity, Metabolic Syndrome, Non-pharmacological Intervention +12

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial

Harpreet S. Bajaj, Richard M. Bergenstal, Andreas Christoffersen et al. · Diabetes Care · 2021 · 120 citations · Full text

Fecal Carriage of ESBL-Producing E. coli and K. pneumoniae in Children in Guinea-Bissau: A Hospital-Based Cross-Sectional Study

Joakim Isendahl, Agata Turlej-Rogacka, Cristovão Manjuba et al. · PLoS ONE · 2012 · 106 citations · Full text

Temporal Dynamics and Risk Factors for Bloodstream Infection With Extended-spectrum β-Lactamase–producing Bacteria in Previously-colonized Individuals: National Population-based Cohort Study

Joakim Isendahl, Christian G. Giske, Ulf Hammar et al. · Clinical Infectious Diseases · 2018 · 48 citations · Full text

Prevalence of community-acquired bacteraemia in Guinea-Bissau: an observational study

Joakim Isendahl, Cristovão Manjuba, Amabélia Rodrigues et al. · BMC Infectious Diseases · 2014 · 28 citations · Full text